Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era

by Andrea Botticelli, Giulia Pomati, Alessio Cirillo, Giulia Mammone, Fabio Ciurluini, Bruna Cerbelli, Paolo Sciattella, Massimo Ralli, Umberto Romeo, Francesca De Felice, Carlo Catalano, Francesco Vullo, Marco Della Monaca, Sasan Amirhassankhani, Silverio Tomao, Valentino Valentini, Marco De Vincentiis, Vincenzo Tombolini, Carlo Della Rocca, Antonella Polimeni, Cira di Gioia, Alessandro Corsi, Giulia D’Amati, Silvia Mezi, Paolo Marchetti
Published 2021-07-01

Conformal radiotherapy in combination with cetuximab for stage Т1–2 tongue cancer with N1–2b regional metastases detected after preventive lymphadenectomy

by D. V. Sikorsky, N. V. Kanishcheva, S. O. Podvyaznikov, D. V. Skamnitsky, S. V. Smetanina, A. M. Ermolaeva, K. V. Bazanov, S. R. Pakhomov
Published 2020-02-01

Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers

by Sandra Ortiz-Cuaran, Jebrane Bouaoud, Jebrane Bouaoud, Jebrane Bouaoud, Andy Karabajakian, Andy Karabajakian, Jérôme Fayette, Jérôme Fayette, Pierre Saintigny, Pierre Saintigny
Published 2021-02-01

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma

by Olivia Leblanc, Sophie Vacher, Charlotte Lecerf, Emmanuelle Jeannot, Jerzy Klijanienko, Frédérique Berger, Caroline Hoffmann, Valentin Calugaru, Nathalie Badois, Anne Chilles, Maria Lesnik, Samar Krhili, Ivan Bieche, Christophe Le Tourneau, Maud Kamal
Published 2020-02-01

Analysis of research on the benefits of clinical and economic effectiveness, safety of innovative drug cetuximab in the treatment of colorectal cancer

by Elena Litvinova
Published 2019-04-01

Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors

by Jesús García-Foncillas, Yu Sunakawa, Dan Aderka, Zev Wainberg, Philippe Ronga, Pauline Witzler, Sebastian Stintzing
Published 2019-09-01

TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer

by Ksenia M. Yegodayev, Ofra Novoplansky, Artemiy Golden, Manu Prasad, Liron Levin, Sankar Jagadeeshan, Jonathan Zorea, Orr Dimitstein, Ben-Zion Joshua, Limor Cohen, Ekaterina Khrameeva, Moshe Elkabets
Published 2020-02-01

Topical Plant Polyphenols Prevent Type I Interferon Signaling in the Skin and Suppress Contact Hypersensitivity

by Maria Luigia Carbone, Daniela Lulli, Francesca Passarelli, Saveria Pastore
Published 2018-09-01

Anaphylactic Reactions to Oligosaccharides in Red Meat: a Syndrome in Evolution

by Saleh Hana, Embry Scott, Nauli Andromeda, Atyia Seif, Krishnaswamy Guha
Published 2012-03-01

Selective Photokilling of Human Pancreatic Cancer Cells Using Cetuximab-Targeted Mesoporous Silica Nanoparticles for Delivery of Zinc Phthalocyanine

by Özge Er, Suleyman Gokhan Colak, Kasim Ocakoglu, Mine Ince, Roger Bresolí-Obach, Margarita Mora, Maria Lluïsa Sagristá, Fatma Yurt, Santi Nonell
Published 2018-10-01

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study

by Yang Li, Qiu-Yan Chen, Lin-Quan Tang, Li-Ting Liu, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Ming-Yuan Chen, Xiang Guo, Ka-Jia Cao, Chao-Nan Qian, Mu-Shen Zeng, Jin-Xin Bei, Jian-Yong Shao, Ying Sun, Jing Tan, Shuai Chen, Jun Ma, Chong Zhao, Hai-Qiang Mai
Published 2017-08-01

Unprecedented Simultaneous and Rapid Reversal of Oral and Alimentary Mucositis using Polymerized Cross Linked Sucralfate: Two Case Reports

by Ricky Wayne McCullough
Published 2014-12-01

Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer

by Dalyong Kim, Sun Young Kim, Ji Sung Lee, Yong Sang Hong, Jeong Eun Kim, Kyu-pyo Kim, Jihun Kim, Se Jin Jang, Young-Kwang Yoon, Tae Won Kim
Published 2017-11-01

Efficacy and Immune Mechanisms of Cetuximab for the Treatment of Metastatic Colorectal Cancer

by Hao Zhuang, Zhen-yi Xue, Lu Wang, Xiao-yan Li, Ning Zhang, Rong-xin Zhang
Published 2011-12-01

Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight

by Peddi P, Paryani B, Takalkar A, Bundrick P, Ponugupati J, Nair B, El-Osta H
Published 2016-02-01

Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study

by Satoshi Dote, Shoji Itakura, Kohei Kamei, Daiki Hira, Satoshi Noda, Yuka Kobayashi, Tomohiro Terada
Published 2018-10-01

Development of radioimmunoconjugate for diagnosis and management of head-and-neck subclinical cancer and colorectal carcinoma

by Raquel Benedetto, Adriana Vidal Fernandes Massicano, Jefferson Jesus Silva, Cristian Antonio Wieczorek Villas Boas, Jair Mengatti, Elaine Bortoleti de Araújo
Published 2018-04-01

<it>Let-7</it> miRNA-binding site polymorphism in the <it>KRAS</it> 3^′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patient...

by Kjersem Janne B, Ikdahl Tone, Guren Tormod, Skovlund Eva, Sorbye Halfdan, Hamfjord Julian, Pfeiffer Per, Glimelius Bengt, Kersten Christian, Solvang Hiroko, Tveit Kjell M, Kure Elin H
Published 2012-11-01

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

by Scartozzi Mario, Giampieri Riccardo, Maccaroni Elena, Mandolesi Alessandra, Biagetti Simona, Alfonsi Simona, Giustini Lucio, Loretelli Cristian, Faloppi Luca, Bittoni Alessandro, Bianconi Maristella, Del Prete Michela, Bearzi Italo, Cascinu Stefano
Published 2012-04-01

The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy

by Hannah Zaryouh, Ines De Pauw, Hasan Baysal, Patrick Pauwels, Patrick Pauwels, Marc Peeters, Marc Peeters, Jan Baptist Vermorken, Jan Baptist Vermorken, Filip Lardon, An Wouters
Published 2021-09-01